Federal Register Notice: FDA is seeking comments on the Experimental Study of Comparative Direct-to-Consumer (DTC) Advertising, designed to explore how consumers understand and interpret DTC ads that explicitly compare the efficacy, dosing, and risks, among other items, of two similar drugs whether comparisons are named or unnamed. Comments should be submitted by 8/30. To view this notice, click here.
